Department of Neurosciences, School of Medical Science, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia.
Singapore Med J. 2012 Jan;53(1):36-9.
The Breast Module (BR23) is increasingly being used worldwide in breast cancer research. This study evaluates the appropriateness of the translated version (i.e. BR23-Malay version) as a useful tool for the Malaysian population who could understand Malay, and examines the reliability and validity of the BR23-Malay version.
This was a prospective study involving 68 Malaysian women who could understand Malay very well. They answered the BR23-Malay version at two evaluation points--three and ten weeks following surgery for breast cancer. Internal consistency, test-retest intraclass correlation coefficients (ICC), effect size index, sensitivity and discriminity of the scale were calculated.
Internal consistencies were acceptable for the functional domains (0.87 for body image; 0.84 for sexual functioning) and symptomatology domains (0.82 for systemic therapy side effect; 0.82 for breast symptoms; 0.70 for arm symptoms). Test-retest ICC ranged from 0.26 to 1.00. Sensitivity of the scale was observed in all domains except sexual functioning.
The Malay version of BR23 is a suitable tool to measure the functional and symptomatology domains of women diagnosed with breast cancer.
乳腺模块(BR23)在全球范围内越来越多地用于乳腺癌研究。本研究评估了翻译版本(即 BR23-马来语版本)作为一种有用工具的适宜性,该工具适用于能够理解马来语的马来西亚人群,并检验了 BR23-马来语版本的可靠性和有效性。
这是一项前瞻性研究,涉及 68 名能够很好地理解马来语的马来西亚女性。她们在乳腺癌手术后的三个和十个星期分别两次回答 BR23-马来语版本。计算了量表的内部一致性、测试-重测内部一致性 ICC、效应大小指数、灵敏度和区分度。
身体形象功能域(0.87)和性健康功能域(0.84)以及症状学域(全身治疗副作用 0.82;乳房症状 0.82;手臂症状 0.70)的内部一致性是可以接受的。测试-重测 ICC 范围为 0.26 至 1.00。除性健康功能域外,各域均观察到了量表的灵敏度。
BR23 的马来语版本是一种适合测量被诊断患有乳腺癌的女性的功能和症状学域的工具。